SevLechner's profile picture. Postdoc in Winter lab, CeMM. Rewiring transcription factors — chemical proteomics — target deconvolution — drug discovery

sev

@SevLechner

Postdoc in Winter lab, CeMM. Rewiring transcription factors — chemical proteomics — target deconvolution — drug discovery

You can now also find me on bluesky @SevLechner.bsky.social


sev reposted

🏆 Congrats to @georg_e_winter for receiving an @ERC_Research Consolidator Grant for GE|NEomorph, a project reprogramming cancer cells via transcription factors. It opens new avenues for targeted therapies in the fight against #cancer #ERCCoG ➡️ Read more: bit.ly/41h3AMG

CeMM_News's tweet image. 🏆 Congrats to @georg_e_winter for receiving an @ERC_Research Consolidator Grant for GE|NEomorph, a project reprogramming cancer cells via transcription factors. It opens new avenues for targeted therapies in the fight against #cancer #ERCCoG ➡️ Read more: bit.ly/41h3AMG

sev reposted

Finally! It is happening! After 6 years of hard work by formidable teams in 13 institutions @RESOLUTE_IMI, we have ordered and validated the results and are able to share the FOUR (4) papers aimed at assigning functional properties to each human SLC #membranetransporter

giuliosf's tweet image. Finally! It is happening! After 6 years of hard work by formidable teams in 13 institutions @RESOLUTE_IMI, we have ordered and validated the results and are able to share the FOUR (4) papers aimed at assigning functional properties to each human SLC #membranetransporter

sev reposted

You have a strong background in bioinformatics🖥️, data science📈, machine learning, and multi omics? You want to do a PhD👩‍🎓facilitating non-clinical safety assessment? If so, come and join our ProteomicsDB team. mls.ls.tum.de/compms/job-off…


sev reposted

Proud to see our 'detective story' on uncovering the MoA of Orpinolide published in its final form in @nchembio! Immensely grateful to @georg_e_winter, the Waldmann lab @mpimoph and @laraialab for being part of this fantastic collaboration!

This post is unavailable.

sev reposted

Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics go.nature.com/4a9lMs8

NatureBiotech's tweet image. Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics go.nature.com/4a9lMs8

sev reposted

We are happy to announce that decryptE is out, another step towards better understanding of drug MoAs. 🎉After elucidating the target space of drugs and how they dose-dependently alter PTMs in cells (decryptM),... (1/4)


sev reposted

...and another new Preprint coming right on its heels! This time by Jakob Trendel and colleagues. doi.org/10.1101/2024.0…


sev reposted

🔬 Research teams led by @georg_e_winter (CeMM) & @alessiociulli (University of Dundee) have found a new system that triggers cellular waste disposal. Published in @Nature, the findings shed light on mechanisms & therapeutic opportunities of this system ➡️ bit.ly/3Pejn8b

CeMM_News's tweet image. 🔬 Research teams led by @georg_e_winter (CeMM) & @alessiociulli (University of Dundee) have found a new system that triggers cellular waste disposal. Published in @Nature, the findings shed light on mechanisms & therapeutic opportunities of this system ➡️ bit.ly/3Pejn8b

sev reposted

Are you a final year international PhD student or PDRA considering opportunities in Chemical Biology in London? Please contact me - the EDV group is on the look for prospective candidates for a Newton Fellowship application to tackle protein phosphatases edv-lab.com/join-us/


sev reposted

Me referring to a 'recent paper' in my writing and realise that 2017 was in fact 6 years ago

Dr_Meming's tweet image. Me referring to a 'recent paper' in my writing and realise that 2017 was in fact 6 years ago

sev reposted

Telos, as they say. Love the consideration of HDAC6 in cardiovascular disease. This deal brings me back to postdoc days in Schreiberia. Cut my teeth as a chemical biologist on HDAC6 with @SchreiberStuart, learning so much from @mazit. Degraders of HDAC6 could be even more…


United States Trends

Loading...

Something went wrong.


Something went wrong.